Print Options

Card layout: ?

← Back to notecard set|Easy Notecards home page

Instructions for Side by Side Printing
  1. Print the notecards
  2. Fold each page in half along the solid vertical line
  3. Cut out the notecards by cutting along each horizontal dotted line
  4. Optional: Glue, tape or staple the ends of each notecard together
  1. Verify Front of pages is selected for Viewing and print the front of the notecards
  2. Select Back of pages for Viewing and print the back of the notecards
    NOTE: Since the back of the pages are printed in reverse order (last page is printed first), keep the pages in the same order as they were after Step 1. Also, be sure to feed the pages in the same direction as you did in Step 1.
  3. Cut out the notecards by cutting along each horizontal and vertical dotted line
To print: Ctrl+PPrint as a list

34 notecards = 9 pages (4 cards per page)

Viewing:

Module 9

front 1

Septicemia, Bacteremia, Toxemia

back 1

  1. What?
    1. Septicemia: any microbial blood infection producing illness.
      1. Lymphangitis: infection and inflammation of lymphatic vessels is a sign of septicemia
    2. Bacteremia: septicemia caused by bacteria
    3. Toxemia: bacteria remain at infection site; release toxins into blood
  2. Signs/Symptoms?- fever, chills, nausea, vomiting, diarrhea, malaise
    1. Septic shock: systemic inflammation = extremely low blood pressure from dilation of vessels
    2. Osteomyelitis: inflammation of the bones (if bacteria invade bones)
    3. Toxemia symptoms: Exotoxin= cytotoxins, neurotoxins; Endotoxin: cause fever, disseminated intravascular coagulation, damaged leaky blood vessels and inflammation lead to low blood pressure = shock
  3. Diagnosis?- signs/symptoms (only ~50% patients have bacteria cultured from blood)

front 2

Endocarditis

back 2

  1. What?- fever, extreme fatigue, malaise, difficulty breathing, and tachycardia (fast heart rate); Inflammation of endocardium (lining inside heart) and vegetations (bulky mass of platelets/clotting to bury bacteria, hiding them from immune system and drugs); embolus (pieces of vegetation/clot) may break off and block vessels
  2. Who?- many bacteria, opportunistic, microbiota; “viridans streptococci” (green pigment in blood culture)= 1/2 infections
  3. Diagnosis?- visualize vegetations via echocardiogram; culture bacteria from blood

front 3

Brucellosis

back 3

  1. What?- fluctuating fever strikes every afternoon; chills, sweating, headache, myalgia, and weight loss
  2. Who?- Brucella : nonmotile, g(-), coccobacilli, no capsule; endotoxin causes some signs/symptoms; intracellular in uterine, placental, and phagocytic cells
  3. How?- contaminated dairy products, animal blood, urine, or placentas; invades through breaks in mucous membrane and travels via phagocytes
  4. Diagnosis?- serological (Ab) test;
  5. Treatment?- usually no treatment needed; attenuated vaccine for animals only

front 4

Tularemia

back 4

  1. What?- skin lesions, swollen lymph nodes @ infection site; then ascending lymphangitis; general manifestations can last months/years
  2. Who?- Francisella : small, nonmotile, obligate aerobe, g(-) coccobacillus, capsule blocks phagocytosis, endotoxin causes many symptoms; can survive phagocytosis by blocking fusion of lysosome to phagosome; has beta-lactamase
  3. How?- via tick bite or contact w/infected animals; small, can enter microabrasions; contact w/dead animals= highest risk
  4. Diagnosis?- difficult, general symptoms, serological test needed which can take weeks to get results
  5. Treatment?- Abx; vaccine for high risk people

front 5

Plague

back 5

  1. Bubonic plague: enlarged lymph nodes called buboes suddenly appear; then tissue death, subsequent gangrene (Clostridium) ; Pneumonic plague: bacterium inhaled or spreads to lungs from blood; develops rapidly (hours)
  2. Who?- Yersinia pestis : g(-) bacillus with capsule; virulence factors= adhesins, capsule, T3SS (antiphagocytic proteins block adaptive immune response)
  3. How?- bubonic: forms biofilm in flea esophagus, starving flea rapidly spreads; endemic in rodents, other mammals = amplifying hosts; contact w/flea feces and infected animals can spread; untreated = 50% fatal <week. Pneumonic: aerosols/ sputum spread, up to 100% fatal
  4. Diagnosis?- symptoms (can be nonspecific)
  5. Treatment?- Abx, rodent/flea control, good hygiene

front 6

Lyme Disease

back 6

  1. What?- three phases in untreated: bulls-eye rash, neurological symptoms (ie. meningitis), and severe arthritis (caused by immune response) that can last years; rarely fatal
  2. Who?- Borrelia - g(-) large spirochete; uses manganese instead of iron for metabolism, alters membrane proteins= evades defenses; dies=endotoxin
  3. How?- via deer tick, needs to be attached 36-48 hrs to infect w/enough bacteria; people moving to woodland areas and protected deer populations = infection rates going up
  4. Diagnosis?- signs/symptoms; bacterium rarely detected, serological for Ab needed
  5. Treatment?- early phase = Abx; late phase = difficult b/c immune system causing most symptoms

front 7

Mononucleosis (Kissing disease; Mono)

back 7

  1. What?- sever sore throat, fever; then swollen lymph nodes, fatigue, appetite loss. Immune system against infected B cells
  2. Who?- Epstein-Barr Virus (EBV, HHV-4): Nveloped dsDNA virus, icosahedral capsid; established latent infection replicating in nucleus; suppresses B-cell apoptosis; can lead to burkitt’s lymphoma and other cancers in certain parts of the world
  3. How?- via saliva; infects B cells which must be killed by cyto-T cells; majority of adults have Ab against EBV
  4. Diagnosis?- presence of large, lobed B-cells and neutropenia (neutrophil deficiency)
  5. Treatment?- relieve symptoms; too widespread to prevent

front 8

CMV Disease

back 8

  1. What?- most asymptomatic; in fetus, newborn, immunocompromised causes hepatomegaly, splenomegaly, jaundice, anemia; may be teratogen
  2. Who?- Cytomegalovirus (CMV): a herpesvirus, infects early in life and remains latent until immunocompromised
  3. How?- via bodily secretions: STD, in utero, transfusions; 50-100% adults
  4. Diagnosis?- signs (enlarged cells, etc)
  5. Treatment?- Fomivirsen (RNAi drug) stops spread; doesn’t cure

front 9

Yellow Fever

back 9

  1. What?- 3 stages: fever, headache, muscle aches; then remission period; then delirium, seizures, coma, hemorrhaging
  2. Who?- yellow fever virus (a flavivirus ): enveloped ssRNA(+), icosahedral capsid; Aedes mosquito vector; monkey reservoir
  3. How?- via Aedes bite; travels to liver to replicate; today in South America and Africa; hasn’t returned to US; 20% mortality rate
  4. Diagnosis?- detect viral Ag in blood
  5. Treatment?- supportive care, vaccine available, mosquito control

front 10

Dengue Fever

back 10

  1. What?- DF two stages: fever, edema, head and muscle pain; then fever returns and red rash. Dengue hemorrhagic fever (DHF): internal bleeding, shock, possibly death= severe hyperimmune response to second viral infection
  2. Who?- Dengue viruses 1, 2, 3, and 4 (flavivirus): enveloped ssRNA(+), icosahedral capsid
  3. How?- Aedes bite, infects monocytes, 1st infection mild, 2nd severe
  4. Diagnosis?- signs/symptoms of people who travel to endemic area; coming back in Florida and Texas
  5. Treatment?- control mosquitoes; vaccine would be bad if it can’t stop hemorrhagic fever once Ab recognize it

front 11

African Viral Hemorrhagic Fever

back 11

  1. What?- fever, fatigue, dizziness, muscle pain, exhaustion; then minor capillary hemorrhaging (petechiae); finally severe internal hemorrhaging, bleeding from orifices; death from shock, seizures, or kidney failure
  2. Who?- Ebolavirus and Marburgvirus : ssRNA(-), filamentous capsid; infected macrophages induce localized blood clotting, depletes clotting proteins = susceptible to massive bleeding
  3. How?- contact of bodily fluids of infected person; possible bat vector; no carrier state; mostly found in Africa
  4. Diagnosis?- symptoms and finding virus in blood
  5. Treatment?- fluid/electrolyte replacement; possible vaccines being studied

front 12

Malaria

back 12

  1. What?- fevers, chills on 2-3 day cycle correlating to cell lysis; anemia, fatigue, weakness
  2. Who?- Plasmodium , 4 species, P. falciparum most severe, P. vivax also common; vector is Anopheles mosquito; Lifecycle; Virulence factors on guide if time available
  3. How?- P. falciparum most severe because adhesins making RBCs stick to capillary walls block blood flow = hemorrhaging and tissue death;
  4. Diagnosis?- Identify Plasmodium in blood
  5. Treatment?- species dependent, many resist chloroquine; heterogenous sickle cell trait = resistance; Duffy resists P. vivax

front 13

Toxoplasmosis

back 13

  1. What?- most asymptomatic; poor immunity = fever, malaise, inflammation of lungs, liver, and heart; Contraction during pregnancy bad
  2. Who?- Toxoplasma gondii : cats definitive hosts; apicomplexan
  3. How?- ingest oocysts from contaminated food, cat fecal matter on hands; pseudocysts ingested from undercooked meat;
  4. Diagnosis?- detect in tissues
  5. Treatment?- only with immunocompromised and pregnant; sulfonamides

front 14

Chagas’ Disease

back 14

  1. What?- swelling, nonspecific symptoms; chronic manifestations many years after infection leading to heart failure
  2. Who?- Trypanosoma cruzi : endemic in south and central America; Triatoma is vector; circulates in bloods with intracellular stage in macrophages and heart muscle cells
  3. How?- Triatoma feces rubbed into bite; a leading cause of death in Latin America
  4. Diagnosis?- identify trypanosomes microscopically; xenodiagnosis (sterile bug takes blood meal, dissect bug a month later)
  5. Treatment?- can only treat early stage (only 1% develop early symptoms)

front 15

Schistosomiasis

back 15

  1. What?- parasitic blood fluke (very common); transient dermatitis due to larval burrowing; eggs in other parts of body can calcify and cause renal failure, heart failure, bladder obstruction, death
  2. Who?- Schistosoma (blood fluke, 3 species): larvae from freshwater snails penetrate human skin, mature and breed in humans, eggs passed into environment via urine or feces, eggs hatch into a different larvae type that infects snails.
  3. How?- swim in ponds with infected snails; not in US
  4. Diagnosis?- identify spiny eggs in stool or urine sample;
  5. Treatment?- praziquantel drugs

front 16

Normal Microbiota of the respiratory system

back 16

Upper respiratory system only: Haemophilus , Veillonella , Staph. aureus , diphtheroids (harmless g(+) that resemble C. diphtheriae ), other g(-) cocci, and alpha-hemolytic streptococci including Strep. pneumoniae

front 17

Streptococcal Respiratory Diseases

back 17

  1. What?- sore throat, difficulty swallowing, can progress to scarlet or rheumatic fever
  2. Who?- group A strep- Strep. pyogenes : g(+) cocci, beta-hemolytic, many virulence factors; occurs when microbiota depleted, large inoculum introduced, or adaptive immunity impaired
  3. How?- respiratory droplets; often in winter or spring
  4. Diagnosis?- often confused with viral pharyngitis; streptococci in throat not diagnostic b/c normal part of pharynx microbiota; must verify species
  5. Treatment?- penicillin

front 18

Diphtheria

back 18

  1. What?- sore throat, fever, oozing intracellular fluid thickens into thick pseudomembrane that can obstruct airways
  2. Who?- Corynebacterium diphtheriae : High G+C, pleomorphic; diphtheria toxin stops protein synthesis = cell death
  3. How?- respiratory droplets or skin contact with non-immunized (100,000s/yr to 2/yr today) or immunocompromised
  4. Diagnosis?- presence of pseudomembrane
  5. Treatment?- antitoxin and Abx; immunize!

front 19

Sinusitis and Otitis Media

back 19

  1. What?- sinusitis: pain and pressure in affected sinus (common in adults); otitis media: severe ear ache (common in kids)
  2. Who?- various microbiota (ie Strep. pneumoniae, Strep. pyogenes, Haemophilus, Moraxella, Staph. aureus)
  3. How?- bacteria in pharynx spread into sinuses via throat
  4. Diagnosis?- symptomatic
  5. Treatment?- penicillin; no prevention

front 20

Common Cold

back 20

  1. What?- sneezing, runny nose, congestion, malaise, sore throat, and cough; lasts ~week; usually no fever
  2. Who?- over 200+ strains; Rhinovirus most common cause: ssRNA+ naked polyhedral; attaches to ICAM-1 protein in nasal cavity cell cytoplasmic membranes; grows best at 33C and neutral pH; lytic; infected cells lose ciliary action, slough off, trigger inflammatory cytokines; stimulated nerves trigger mucus production and sneezing; localized inflammation = congestion
  3. How?- aerosols via sneezing/coughing, fomites, contact
  4. Diagnosis?- symptomatic
  5. Treatment?- symptom relief

front 21

Pneumococcal pneumonia

back 21

  1. lobar; 85% of pneumonia cases; short, rapid breathing; rust colored sputum; neutrophils in sputum
  2. Who?- Strep. pneumoniae : g(+); adhesins, capsule, and toxin pneumolysin (binds cholesterol in PM of ciliated cells, creates pores that lyses them; neutralizes lysosomes in phagocytes)
  3. How?- inhalation into (usually damaged) lungs; bacteria endocytosed by lung cells, replicate and lyse, damages lining which allows fluid from blood into alveoli, WBC attack bacteria causing inflammation and more fluid
  4. Diagnosis?- streptococci in sputum smears
  5. Treatment?- penicillin; vaccine given to kids

front 22

Primary Atypical (Mycoplasmal) Pneumonia

back 22

  1. pneumonia + mild symptoms including fever, malaise, sore throat, excessive sweating
  2. Who?- Mycoplasma : low G+C obligate aerobe, encapsulated, no cell wall, sterols in PM, small; adhesion protein allows attachment to base of cilia on epithelial cells
  3. How?- by nasal secretions
  4. Diagnosis?- difficult
  5. Treatment?- tetracycline or erythromycin

front 23

Klebsiella Pneumonia (Nosocomial Pneumonia)

back 23

  1. normal symptoms plus thick bloody sputum (destroys alveoli) and recurrent chills; often nosocomial
  2. Who?- Klebsiella : g(-) bacillus w/prominent capsule, endotoxin
  3. Diagnosis?- symptomatic and culture from sputum
  4. Treatment?- supportive; abx available but endotoxin creates severe and permanent damage to lungs, sometimes fatal.

front 24

Legionnaires’ Disease

back 24

  1. What?- pneumonia symptoms, pulmonary fxn rapidly decreases, 50% mortality if untreated
  2. Who?- Legionella : g(-), aerobic, pleomorphic; nutrient needy; intracellular parasite of freshwater protozoan phagosomes, protozoa release bacteria-filled vesicles that are inhaled by human host, into macrophages
  3. How?- survives in domestic water sources (showers, hot tubs, AC) kills human cells, causes tissue damage and inflammation, rarely spreads outside lungs
  4. Diagnosis?- fluorescent Ab staining, serological
  5. Treatment?- quinolone, macrolides; reduce bacteria in water

front 25

Tuberculosis

back 25

  1. What?- fever, cough, fatigue, chest pain, wheezing, coughing up blood, tubercles in lungs
  2. Who?- Mycobacterium tuberculosis : mycolic acid = slow growth and resistances, viable in aerosols for long time; replicate freely in macrophages. Primary tb: can develop tubercles (caseous necrosis in center). Secondary tb: reactivation by escaping tubercle. Disseminated tb: systemic infection (macrophages carry to other parts of body)
  3. How?- inhaled; alveolar macrophages endocytose; bacteria divide freely in macrophage; more macrophages come, get infected or sequester into tubercle; center macrophages die = caseous necrosis = stalemate; 10% people lose stalemate, often decades later = reactivation
  4. Diagnosis?- Tuberculin skin test, chest x-ray for tubercles,
  5. Treatment?- combo of drugs for months; resistant strains emerging, BCG vaccine sometimes available (effective?)

front 26

Pertussis

back 26

  1. What?- initially cold-like symptoms, then persistent powerful cough that fatigues, turning blue, ruptured eye vessels
  2. Who?- Bordetella : small, aerobic, nonmotile, g(-) coccobacillus; numerous virulence factors; bind cilia in trachea, stop ciliary elevator, invade neutrophils, survive in phagosomes, invade respiratory epithelial cells
  3. How?- highly contagious via airborne respiratory droplets, life threatening in children
  4. Diagnosis?- symptomatic
  5. Treatment?- supportive, prevent with DTaP vaccine

front 27

Inhalational Anthrax

back 27

  1. What?- initially resembles cold or flu, then severe coughing, lethargy, shock, and death
  2. Who?- Bacillus anthracis : g(+), endospore forming, hemolytic, aerobic; capsule and anthrax toxin kills human cells and edema
  3. How?- contact or inhalation of anthrax, most die
  4. Diagnosis?- identify in sputum
  5. Treatment?- aggressive abx; vaccine for select individuals

front 28

Influenza

back 28

  1. What?- sudden fever, pharyngitis, fatigue, congestion, cough
  2. Who?- Influenza virus A and B: ssRNA(-), enveloped, HA and NA glycoprotein spikes. NA hydrolyzes mucus to give access to cell surface; HA attaches to host epithelial cells and triggers endocytosis; symptoms are immune response to virus (cytokines and inflammation); damages lung epithelium, secondary bacterial infection possible (ie. Haemophilus )
  3. How?- inhalation or self-inoculation; complications most often in elderly, kids, weak immune system
  4. Diagnosis?- symptomatic with community outbreak
  5. Treatment?- supportive care; yearly multivalent vaccine

front 29

SARS (severe acute respiratory syndrome)

back 29

  1. What?- high fever, shortness of breath, difficulty breathing; 10% mortality
  2. Who?- a Coronavirus called SARS Virus: ssRNA(+), enveloped, helical capsid
  3. How?- via respiratory droplets
  4. Diagnosis?- via signs/symptoms
  5. Treatment?- supportive treatment

front 30

RSV (respiratory syncytial virus)

back 30

  1. What?- most common respiratory disease in newborns and young children; fever, runny nose, cyanosis (blue cast to skin), coughing, sometimes wheezing. Causes inflamed bronchioles (bronchiolitis) and pneumonia in infants, #1 respiratory killer of infants worldwide
  2. Who?- Respiratory Syncytial Virus : ssRNA(-), enveloped; causes syncytia to form in lungs, immune responses to RSV damages lungs
  3. How?- via close contact (kissing, touching), fomites, and sometimes respiratory droplets (less common)
  4. Diagnosis?- symptoms and immunoassay
  5. Treatment?- supportive care in young children; Ab against RSV and inhaled ribavirin in severe cases

front 31

Hantavirus Pulmonary Syndrome

back 31

  1. What?- cough, shock, and labored breathing; 4-10 days after infection 50% die
  2. Who?- Hantavirus : segmented (3 pieces) ssRNA(-), enveloped; invades blood capillary walls and lungs, then widespread inflammation and shock
  3. How?- inhalation of mouse excrement; not contagious by contact
  4. Diagnosis?- based on symptoms
  5. Treatment?- none; control rodents

front 32

Coccidioidomycosis (Valley Fever)

back 32

  1. What?- resembles pneumonia or TB, may become systemic
  2. Who?- Coccidioides : dimorphic soil Ascomycota fungus; grow as mycelial filaments and produce spores in soil
  3. How?- inhalation of conidia by mammals, converts to yeast form at body temp, germinate in alveoli into spherules with lots of spores; almost exclusive to southwestern US and northern Mexico
  4. Diagnosis?- presence of spherules in clinical specimens
  5. Treatment?- amphotericin B; masks reduce to conidia exposure

front 33

Histoplasmosis *** (Prof's fave)

back 33

  1. What?- most common fungal systemic disease in humans; asymptomatic in 95% of cases, otherwise coughing with bloody sputum or skin lesions, splenomegaly, hepatomegaly
  2. Who?- Histoplasma capsulatum : dimorphic soil ascomycete; in moist soils with bird or bat droppings; yeast form pathogenic at body temp
  3. How?- inhalation, then intracellular in alveolar macrophages, then spread systemically via blood/lymph; prevalent in eastern US
  4. Diagnosis?- identification from clinical samples
  5. Treatment?- no treatment needed in immunocompetent

front 34

Respiratory fungal pathogenesis

back 34

(1)Aerosolization of conidia; (2)Inhalation of conidia by host; (3)Travel into deep lung (alveoli); (4)Encounter innate immune cells

  1. Fungal cell wall components: alpha and beta-glucan, specific glycoproteins/polysaccharides
  2. Complement can bind wall; macrophage complement receptor 3 (CR3) recognizes complement and cell wall proteins
  3. Macrophage Dectin-1 recognizes beta-glucan
  4. Macrophage TLR-2 and -4 recognize glycoproteins and polysaccharides

(5) Conidia phagocytosed by macrophages; Two options: some degraded by macrophages/ other immune cells, some survive and replicate inside innate immune cells

(6) Dissemination to other organs: either degraded by cell-mediated response in 7-10 days OR overwhelm immune system=fungal sepsis